Kalundborg is in the top 5% of towns in Denmark for overweight children ... the golden child of the Danish economy since its weight-loss-aiding drugs became popular beyond diabetic patients.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Trump threatened "very high" tariffs on Denmark amid Greenland dispute, raising fears of higher prices for Danish pharmaceuticals.

Novo Nordisk A/S rose the most in a month after an experimental shot delivered as much as 22% weight loss in an early-stage ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

after disappointing results from a late-stage trial of a new weight-loss drug drove a big fall in the shares of Denmark's largest company, Novo Nordisk. Novo Nordisk's drug trial results weaken ...

Denmark-based pharma giant Novo Nordisk has ... having found huge success with its weight-loss and type 2 diabetes injections Wegovy and Ozempic. The company expects to significantly increase ...

the popular weight-loss drugs. The company is so important to the Danish economy — it has recently accounted for half of Denmark’s private sector job growth and all of the country’s economic ...